Docosanol topical Pregnancy and Breastfeeding Warnings
Brand names: Abreva
Medically reviewed by Drugs.com. Last updated on Dec 8, 2023.
Docosanol topical Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
The manufacturer makes no recommendation regarding use in pregnancy.
US FDA pregnancy category: Not formally assigned to a pregnancy category.
Docosanol topical Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Abreva (docosanol topical). SmithKline Beecham. 2001;PROD.
- MedicinesComplete. Pharmaceutical Press. Martindale: the Complete Drug Reference. http://www.medicinescomplete.com/mc/martindale/current/ 2011.
References for breastfeeding information
- Product Information. Abreva (docosanol topical). SmithKline Beecham. 2001;PROD.
- MedicinesComplete. Pharmaceutical Press. Martindale: the Complete Drug Reference. http://www.medicinescomplete.com/mc/martindale/current/ 2011.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
